Reviewing Nexalin Technology (NASDAQ:NXL) & Tivic Health Systems (NASDAQ:TIVC)

Nexalin Technology (NASDAQ:NXL) and Tivic Health Systems (NASDAQ:TIVC) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, institutional ownership and profitability.

Analyst Ratings

This is a summary of recent ratings for Nexalin Technology and Tivic Health Systems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexalin Technology	0	0	0	0	N/A
Tivic Health Systems	0	0	0	0	N/A

Risk & Volatility

Nexalin Technology has a beta of 5.68, meaning that its share price is 468% more volatile than the S&P 500. Comparatively, Tivic Health Systems has a beta of 2.5, meaning that its share price is 150% more volatile than the S&P 500.

Earnings and Valuation

This table compares Nexalin Technology and Tivic Health Systems’ revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexalin Technology	$110,000.00	77.97	-$4.65 million	($0.66)	-1.23
Tivic Health Systems	$1.18 million	1.66	-$8.24 million	N/A	N/A

Nexalin Technology has higher earnings, but lower revenue than Tivic Health Systems.

Profitability

This table compares Nexalin Technology and Tivic Health Systems’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexalin Technology	-3,581.94%	-213.55%	-173.44%
Tivic Health Systems	-606.47%	-172.08%	-133.45%

Institutional and Insider Ownership

0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 4.3% of Tivic Health Systems shares are owned by institutional investors. 27.7% of Nexalin Technology shares are owned by insiders. Comparatively, 0.4% of Tivic Health Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Tivic Health Systems beats Nexalin Technology on 5 of the 9 factors compared between the two stocks.

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.

About Tivic Health Systems

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.